Literature DB >> 6313270

The modern diagnosis of cardiac myxoma: role of two-dimensional echocardiography.

K M McGarry, B I Jugdutt, R E Rossall.   

Abstract

We reviewed our experience with the diagnosis of cardiac myxoma in 10 patients seen between 1960 and 1981. At surgery, large myxomas (greater than 5 cm) were found in the left atrium in 6 patients, right atrium in 3, and right ventricle in 1. The correct preoperative diagnosis was made in 9 patients: clinically in 3 and at catheterization and angiocardiography in 6. Diagnoses were falsely negative in 3/13 (23%) catheterizations and 2/10 (20%) angiocardiograms. Echocardiography (echo) was positive in 5/5 (100%). Gated blood-pool scans confirmed a right atrial myxoma in 1 patient. The interval between onset of symptoms and surgery was 30.5 months, (range, 2-120) and was not significantly different in the eras before and after echo. The age at diagnosis exceeded 40 years in 9 patients and was not significantly less in the echo era. The size and site of the tumor at surgery agreed with findings on M-mode echo (n=5) or two-dimensional (2-D) echo (n=2), but the size (85 vs. 88 cm3) and mass (81 vs. 88 g) of the tumors were similar in the 2 eras. Although 2-D echo facilitates the preoperative diagnosis of cardiac myxoma, earlier patient referral of suspicious cases for 2-D echo is still necessary.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313270     DOI: 10.1002/clc.4960061008

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  Right atrial myxoma developing 4 years following patch closure of an atrial septal defect: report of a case.

Authors:  I Suzuki; S Koide; S Odagiri; A Shohtsu
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

2.  A case report of left atrial myxoma-induced acute myocardial infarction and successive stroke.

Authors:  Qiushuang Wang; Feifei Yang; Fei Zhu; Cunshan Yao
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.